Financhill
Sell
19

FSOYF Quote, Financials, Valuation and Earnings

Last price:
$0.86
Seasonality move :
6.99%
Day range:
$0.86 - $0.86
52-week range:
$0.86 - $1.21
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.95x
P/B ratio:
1.61x
Volume:
--
Avg. volume:
--
1-year change:
-6.77%
Market cap:
$151M
Revenue:
$154.6M
EPS (TTM):
-$0.22
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $243.3M $251.5M $153.8M $142.1M $154.6M
Revenue Growth (YoY) 8.03% 3.36% -38.83% -7.66% 8.84%
 
Cost of Revenues $56.6M $54.8M $49.1M $49.5M $46.1M
Gross Profit $186.7M $196.7M $104.8M $92.5M $108.5M
Gross Profit Margin 76.74% 78.2% 68.1% 65.13% 70.16%
 
R&D Expenses $44.3M $47.8M $38M $41.3M $51.2M
Selling, General & Admin $150.1M $128.8M $105.3M $109.1M $115.4M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $192.8M $174.2M $141M $139.1M $158.1M
Operating Income -$6.1M $22.5M -$36.2M -$46.6M -$49.6M
 
Net Interest Expenses $2.4M $1.3M $1.2M $843.7K --
EBT. Incl. Unusual Items $4.8M $18.8M -$36M -$46.6M -$47.3M
Earnings of Discontinued Ops. -- -- $45.1M $494.1M --
Income Tax Expense $987.4K $4.1M -$5.9M -$6.3M -$4M
Net Income to Company $3.8M $14.7M $15M $453.8M -$43.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $3.8M $14.7M $15M $453.8M -$43.3M
 
Basic EPS (Cont. Ops) $0.02 $0.09 $0.08 $2.58 -$0.25
Diluted EPS (Cont. Ops) $0.02 $0.09 $0.08 $2.58 -$0.25
Weighted Average Basic Share $157.7M $158.1M $158.4M $171.3M $175.6M
Weighted Average Diluted Share $157.7M $158.1M $158.4M $171.3M $175.6M
 
EBITDA $32.7M $38.1M -$17.3M -$32.2M -$26.2M
EBIT $5.8M $19.8M -$35.2M -$45.9M -$46.5M
 
Revenue (Reported) $243.3M $251.5M $153.8M $142.1M $154.6M
Operating Income (Reported) -$6.1M $22.5M -$36.2M -$46.6M -$49.6M
Operating Income (Adjusted) $5.8M $19.8M -$35.2M -$45.9M -$46.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $63.7M $37.8M $33.8M $37.9M $39.8M
Revenue Growth (YoY) 6.54% -40.62% -10.81% 12.14% 5.03%
 
Cost of Revenues $13.8M $11.9M $11.7M $11.5M $10.9M
Gross Profit $49.9M $25.9M $22.1M $26.3M $28.9M
Gross Profit Margin 78.35% 68.54% 65.34% 69.55% 72.58%
 
R&D Expenses $11.2M $9.1M $10M $11.7M $10.7M
Selling, General & Admin $31.1M $24.4M $23.9M $29.2M $38.4M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $41.9M $33.1M $28.2M $39.1M $48M
Operating Income $8.1M -$7.2M -$6.1M -$12.8M -$19.1M
 
Net Interest Expenses $701.6K $235.8K $333.4K -- $672K
EBT. Incl. Unusual Items $7.4M -$7.4M -$6.5M -$12.7M -$19.5M
Earnings of Discontinued Ops. -- $12.5M -- -- --
Income Tax Expense $1.5M -$1.5M -$1.5M -$1.4M -$268.4K
Net Income to Company $6.2M $6.4M $460.5M -$11.3M -$19.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $5.8M $6.6M -$4.9M -$11.3M -$19.3M
 
Basic EPS (Cont. Ops) $0.04 $0.04 -$0.03 -$0.07 -$0.11
Diluted EPS (Cont. Ops) $0.04 $0.04 -$0.03 -$0.07 -$0.11
Weighted Average Basic Share $166.7M $186.7M $163.7M $172.9M $175.3M
Weighted Average Diluted Share $166.7M $186.7M $163.7M $172.9M $175.3M
 
EBITDA $8.1M -$3.2M -$3M -$2.7M $1.4M
EBIT $8.1M -$7.2M -$6.1M -$12.8M -$19.1M
 
Revenue (Reported) $63.7M $37.8M $33.8M $37.9M $39.8M
Operating Income (Reported) $8.1M -$7.2M -$6.1M -$12.8M -$19.1M
Operating Income (Adjusted) $8.1M -$7.2M -$6.1M -$12.8M -$19.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $244.7M $183.3M $144.1M $150.9M $159.7M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $54.5M $50.9M $49.3M $47.8M $44.7M
Gross Profit $190.1M $132.4M $94.9M $103.1M $115M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $45.2M $41.1M $40.9M $49.7M $45.2M
Selling, General & Admin $131.5M $114.6M $109.5M $107.9M $111M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $184.5M $153.9M $142.9M $143.4M $153.7M
Operating Income $5.6M -$21.5M -$48M -$40.4M -$38.8M
 
Net Interest Expenses $2.4M -- $1.6M -- $240.9K
EBT. Incl. Unusual Items $16.2M -$22.5M -$48.2M -$47.1M -$37M
Earnings of Discontinued Ops. -- $35.3M $509.6M -- --
Income Tax Expense $4M -$4.7M -$6.4M -$8.3M $1.2M
Net Income to Company $12.5M $16.8M $442.4M -$18.5M -$38.2M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $12.1M $17.4M $467.8M -$38.7M -$38.2M
 
Basic EPS (Cont. Ops) $0.06 $0.11 $2.66 -$0.22 -$0.22
Diluted EPS (Cont. Ops) $0.06 $0.11 $2.66 -$0.22 -$0.22
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $17.5M -$16.1M -$31.2M -$19.5M -$5.1M
EBIT $17.5M -$24.3M -$47M -$39.7M -$35.7M
 
Revenue (Reported) $244.7M $183.3M $144.1M $150.9M $159.7M
Operating Income (Reported) $5.6M -$21.5M -$48M -$40.4M -$38.8M
Operating Income (Adjusted) $17.5M -$24.3M -$47M -$39.7M -$35.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $182.6M $114.3M $104.6M $113.7M $118.8M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $40.3M $36.4M $36.6M $35M $33.5M
Gross Profit $142.3M $77.9M $68M $78.7M $85.3M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $33.8M $27.2M $30.3M $38.8M $33M
Selling, General & Admin $91.6M $77.1M $81.4M $80.1M $82.3M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $123.6M $102.9M $104.9M $108.9M $112.6M
Operating Income $18.8M -$25M -$36.9M -$30.1M -$27.4M
 
Net Interest Expenses $2.9M $717.9K $857.7K -- $672K
EBT. Incl. Unusual Items $15.7M -$25.5M -$37.8M -$37.7M -$27.4M
Earnings of Discontinued Ops. -- $35.3M $499.6M -- --
Income Tax Expense $4.2M -$4.5M -$5.1M -$7M -$1.9M
Net Income to Company $11.9M $14M $441.4M -$30.8M -$25.7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $11.6M $14.2M $466.9M -$30.7M -$25.5M
 
Basic EPS (Cont. Ops) $0.06 $0.08 $2.66 -$0.17 -$0.14
Diluted EPS (Cont. Ops) $0.06 $0.08 $2.66 -$0.17 -$0.14
Weighted Average Basic Share $482.9M $490M $521.5M $529M $532.9M
Weighted Average Diluted Share $482.9M $490M $521.5M $529M $532.9M
 
EBITDA $18.8M -$16.8M -$26.5M -$13.2M -$350.5K
EBIT $18.8M -$25M -$36.9M -$30.1M -$27.4M
 
Revenue (Reported) $182.6M $114.3M $104.6M $113.7M $118.8M
Operating Income (Reported) $18.8M -$25M -$36.9M -$30.1M -$27.4M
Operating Income (Adjusted) $18.8M -$25M -$36.9M -$30.1M -$27.4M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $28.5M $63.2M $59.9M $59.1M $40.5M
Short Term Investments $73.9K $75K $69.1K $15M $28.7K
Accounts Receivable, Net $49.5M $46.8M $43.3M $28.3M $27.9M
Inventory $119.9K $91K $57.7K -- --
Prepaid Expenses $8.3M $9.7M $10.6M $7.8M $6.1M
Other Current Assets -- -- $40.8K $255.2K --
Total Current Assets $95.4M $127M $123.8M $120.8M $85.3M
 
Property Plant And Equipment $17.5M $17.3M $13.6M $11.4M $14.4M
Long-Term Investments -- -- -- -- --
Goodwill $99M $100.8M $96.4M $89M $86.3M
Other Intangibles $40.9M $41.8M $38.2M $25.3M $22.7M
Other Long-Term Assets -$4.5K -$1.2K $4.5K $37.5K --
Total Assets $256.9M $292.5M $278.8M $263.6M $229.3M
 
Accounts Payable $4.6M $5.1M $6.8M $4.7M $19.9M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $10.5M $11.5M $7.7M $6M --
Total Current Liabilities $110.6M $129M $119M $78.6M $81.4M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $171.6M $191.2M $170.8M $113.4M $115.4M
 
Common Stock $1.7M $1.9M $1.8M $85.8K $88.4K
Other Common Equity Adj -- -- -- -- --
Common Equity $85.3M $101.3M $108M $150.2M $113.8M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $85.3M $101.3M $108M $150.2M $113.8M
 
Total Liabilities and Equity $256.9M $292.5M $278.8M $263.6M $229.3M
Cash and Short Terms $28.6M $63.3M $60M $74.1M $40.5M
Total Debt $46.3M $49M $32.2M $14.2M $15.2M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $50.1M $50.6M $73.8M $31.8M $24.1M
Short Term Investments $117.4K $116K -- $6.3M $29K
Accounts Receivable, Net $52.6M $53.9M $31.5M $31.7M $32.9M
Inventory $117.4K $116K -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets $112M $112.7M $115.3M $79.2M $75M
 
Property Plant And Equipment $18.7M $14.6M $9.9M $14.7M $26.2M
Long-Term Investments -- -- -- -- --
Goodwill $92.6M $98.2M $81.9M $82.9M $72.4M
Other Intangibles $39.7M $39.8M $24.1M $22.8M $19.7M
Other Long-Term Assets $117.4K -- -$98.3K -- --
Total Assets $267.3M $271.4M $246.2M $222M $214.6M
 
Accounts Payable $25.2M $26.2M $19.1M $14.5M $16.2M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $5.3M $5.3M -- -- --
Other Current Liabilities -- -- -- -$1.1K --
Total Current Liabilities $114.5M $109.5M $69.1M $68.2M $76.2M
 
Long-Term Debt $25.8M $18.6M -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $177.4M $163.2M $102.2M $101.5M $120.6M
 
Common Stock $1.9M $1.9M $98.3K $84.7K $89.4K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $89.9M $108.2M $144M $120.5M $94M
 
Total Liabilities and Equity $267.3M $271.4M $246.2M $222M $214.6M
Cash and Short Terms $50.2M $50.7M $73.8M $38.1M $24.1M
Total Debt $44.5M $25.5M $13.4M $16M $27.9M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $3.8M $14.7M $15M $453.8M -$43.3M
Depreciation & Amoritzation $26.9M $18.3M $17.8M $13.7M $20.4M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$1.7M $7M -$4.9M -$9.4M $5M
Change in Inventories $322.4K $37.7K $27.2K $6.3K --
Cash From Operations $20.7M $53.3M $36.4M -$21.3M -$25M
 
Capital Expenditures $9.7M $9.3M $7.8M $5M $5.6M
Cash Acquisitions -- -$4.2M -- -$774.1K $1.7M
Cash From Investing -$9.5M -$13.2M -$7.3M -$20.5M $12.2M
 
Dividends Paid (Ex Special Dividend) -- -- -$7.5M -- --
Special Dividend Paid
Long-Term Debt Issued -- $11.4M -- -- --
Long-Term Debt Repaid -$6.7M -$12.6M -$13M -$20M --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -$1.2K -- --
Cash From Financing -$13.9M -$9.4M -$27.6M $53.8M -$6.6M
 
Beginning Cash (CF) $31.1M $29M $60.8M $55.8M $59.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$2.8M $30.7M $1.5M $11.9M -$19.4M
Ending Cash (CF) $28.5M $58.7M $62.6M $58.1M $39.6M
 
Levered Free Cash Flow $11M $44M $28.6M -$26.4M -$30.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $6.2M $6.4M $460.5M -$11.3M -$19.4M
Depreciation & Amoritzation -- $3.8M $3.1M $2.8M $20.6M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $9.2M $2.1M -$2.4M -$10.5M -$1.8M
 
Capital Expenditures $1.7M $1.7M -$698K $1.6M $2.7M
Cash Acquisitions -$251.9K -- -$1.5M $965.7K $1.4M
Cash From Investing -$2M -$1.7M $4.4M $13.4M -$1.3M
 
Dividends Paid (Ex Special Dividend) -- $164.6K -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $680.8K -- -- -- --
Long-Term Debt Repaid -$204.2K $209K -$19.1M -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- $120.5K -- -- --
Cash From Financing -$2.3M -$1.3M $56.6M -$1.5M -$2M
 
Beginning Cash (CF) $43.7M $53.4M $30.7M $31.4M $27.6M
Foreign Exchange Rate Adjustment -$591.5K $235.8K $828K -$59.9K $323.4K
Additions / Reductions $5M -$878.3K $58.5M $1.5M -$5.1M
Ending Cash (CF) $49.9M $51.4M $75.6M $32.7M $23.7M
 
Levered Free Cash Flow $7.5M $435.7K -$1.7M -$12.1M -$4.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $12.5M $16.8M $442.4M -$18.5M -$38.2M
Depreciation & Amoritzation -- -- $15.4M $20.9M $30.5M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $39.1M $41.9M -$866.3K -$29.8M -$5.8M
 
Capital Expenditures $9.8M $8.1M $4.9M $7.4M $6.2M
Cash Acquisitions -$4.3M $123K -$741.4K $1.7M $2.6M
Cash From Investing -$14M -$7.7M -$5.2M -$11.7M $3.6M
 
Dividends Paid (Ex Special Dividend) -- -$7.4M -$66.2K -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -$18.5M -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -$3.4M -$33.7M $48.1M -$4.3M -$7.2M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $21.7M $538.1K $42.1M -$45.8M -$9.3M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $29.3M $33.8M -$5.8M -$37.2M -$12M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $11.9M $14M $441.4M -$30.8M -$25.7M
Depreciation & Amoritzation -- $12.3M $9.8M $17M $27.1M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $30.2M $18.7M -$18.5M -$26.9M -$7.8M
 
Capital Expenditures $7M $5.8M $2.9M $5.3M $6M
Cash Acquisitions -$4.3M -- -$741.4K $1.7M $2.6M
Cash From Investing -$11.3M -$5.8M -$3.7M $5.2M -$3.4M
 
Dividends Paid (Ex Special Dividend) -- -$7.4M -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $11.7M -- -- -- --
Long-Term Debt Repaid -$3.5M -$9.4M -$19.1M -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $2M -$22.3M $53.4M -$4.8M -$5.3M
 
Beginning Cash (CF) $100.7M $172.1M $226.4M $127.6M $102.5M
Foreign Exchange Rate Adjustment -$701.7K $235.8K $105.8K -$799.2K -$86.9K
Additions / Reductions $20.8M -$9.3M $31.2M -$26.5M -$16.5M
Ending Cash (CF) $122.6M $161.6M $242.6M $101.1M $86.4M
 
Levered Free Cash Flow $23.2M $13M -$21.4M -$32.3M -$13.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock